NYSE:AVNS Avanos Medical (AVNS) Stock Price, News & Analysis $23.12 +0.20 (+0.87%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$22.80▼$23.3550-Day Range$18.95▼$22.9152-Week Range$17.24▼$25.04Volume160,623 shsAverage Volume247,273 shsMarket Capitalization$1.06 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Avanos Medical alerts: Email Address Avanos Medical MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy1.68% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.71Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth31.16%From $1.38 to $1.81 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.18 out of 5 starsMedical Sector367th out of 936 stocksSurgical Appliances & Supplies Industry10th out of 18 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Avanos Medical.Read more about Avanos Medical's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.68% of the float of Avanos Medical has been sold short.Short Interest Ratio / Days to CoverAvanos Medical has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Avanos Medical has recently decreased by 11.03%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAvanos Medical does not currently pay a dividend.Dividend GrowthAvanos Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVNS. Previous Next 3.2 News and Social Media Coverage News SentimentAvanos Medical has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Avanos Medical this week, compared to 2 articles on an average week.Search Interest2 people have searched for AVNS on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows1 people have added Avanos Medical to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Avanos Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.90% of the stock of Avanos Medical is held by insiders.Percentage Held by Institutions95.17% of the stock of Avanos Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Avanos Medical's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Avanos Medical are expected to grow by 31.16% in the coming year, from $1.38 to $1.81 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Avanos Medical is -17.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Avanos Medical is -17.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAvanos Medical has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Avanos Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIHow a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…Click now to see for yourself what $0.25 Cent Trades is all about About Avanos Medical Stock (NYSE:AVNS)Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.Read More AVNS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVNS Stock News HeadlinesJuly 25 at 3:44 PM | finance.yahoo.comAvanos Medical (NYSE:AVNS) investors are sitting on a loss of 44% if they invested five years agoJuly 24 at 6:14 PM | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial ResultsJuly 26, 2024 | WealthPress (Ad)New trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.July 18, 2024 | americanbankingnews.comZacks Research Comments on Avanos Medical, Inc.'s Q1 2026 Earnings (NYSE:AVNS)July 17, 2024 | americanbankingnews.comBrokers Set Expectations for Avanos Medical, Inc.'s Q4 2025 Earnings (NYSE:AVNS)July 1, 2024 | prnewswire.comAvanos Medical, Inc. Appoints Indrani Franchini to Board of DirectorsMay 13, 2024 | prnewswire.comAvanos Medical, Inc. Appoints Sig Delgado as Senior Vice President, Integrated Supply ChainMay 6, 2024 | finance.yahoo.comAvanos Medical, Inc. (NYSE:AVNS) Q1 2024 Earnings Call TranscriptJuly 26, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.May 3, 2024 | finance.yahoo.comAvanos Medical First Quarter 2024 Earnings: EPS: US$0.011 (vs US$0.17 loss in 1Q 2023)May 3, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...May 2, 2024 | msn.comAVNS Stock Earnings: Avanos Medical Misses EPS, Beats Revenue for Q1 2024May 2, 2024 | finance.yahoo.comAvanos Medical Inc (AVNS) Q1 2024 Earnings: Aligns with EPS Projections, Surpasses Revenue EstimatesMay 2, 2024 | sfgate.comAvanos Medical: Q1 Earnings SnapshotMay 2, 2024 | prnewswire.comAvanos Medical, Inc. Announces First Quarter 2024 ResultsMay 1, 2024 | msn.comAvanos Medical Q1 2024 Earnings PreviewApril 25, 2024 | prnewswire.comAvanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial ResultsApril 19, 2024 | finance.yahoo.comHere's Why Shareholders May Want To Be Cautious With Increasing Avanos Medical, Inc.'s (NYSE:AVNS) CEO Pay PacketSee More Headlines Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)7/31/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNYSE:AVNS CUSIPN/A CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees3,771Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.33) Trailing P/E RatioN/A Forward P/E Ratio16.70 P/E GrowthN/ANet Income$-61,800,000.00 Net Margins-9.15% Pretax Margin0.40% Return on Equity4.10% Return on Assets2.99% Debt Debt-to-Equity Ratio0.14 Current Ratio2.28 Quick Ratio1.47 Sales & Book Value Annual Sales$673.30 million Price / Sales1.57 Cash Flow$2.06 per share Price / Cash Flow11.17 Book Value$26.63 per share Price / Book0.87Miscellaneous Outstanding Shares45,900,000Free Float44,573,000Market Cap$1.06 billion OptionableOptionable Beta0.94 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Joseph F. Woody (Age 58)CEO & Director Comp: $2.21MMr. Michael C. Greiner (Age 51)Senior VP, CFO & Chief Transformation Officer Comp: $986.42kMs. Mojirade James (Age 57)Senior VP, General Counsel & Corporate Secretary Comp: $728.66kMr. Kerr W. Holbrook (Age 57)Senior VP & Chief Commercial Officer Comp: $747.61kMr. Sudhakar Varshney (Age 47)Senior Vice President of Global Supply Chain & Procurement Comp: $1.02MMr. John Joseph HurleyPrincipal Accounting Officer & ControllerMr. David CrawfordVP of FP&A and Investor Relations and TreasurerMs. Michelle ScharfenbergSenior VP and Chief Ethics & Compliance OfficerMr. Scott GalovanVice President of Strategy & Corporate DevelopmentJohn W. CatoVice President of Human ResourcesMore ExecutivesKey CompetitorsPROCEPT BioRoboticsNASDAQ:PRCTInari MedicalNASDAQ:NARIiRhythm TechnologiesNASDAQ:IRTCCONMEDNYSE:CNMDNovoCureNASDAQ:NVCRView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpSold 9,112 shares on 7/26/2024Ownership: 0.833%Tributary Capital Management LLCBought 601 shares on 7/25/2024Ownership: 1.619%Westwood Holdings Group Inc.Sold 36,559 shares on 6/6/2024Ownership: 4.607%Boston PartnersBought 28,685 shares on 5/28/2024Ownership: 0.062%Comerica BankSold 2,323 shares on 5/17/2024Ownership: 0.055%View All Insider TransactionsView All Institutional Transactions AVNS Stock Analysis - Frequently Asked Questions How have AVNS shares performed this year? Avanos Medical's stock was trading at $22.43 at the beginning of 2024. Since then, AVNS stock has increased by 3.1% and is now trading at $23.12. View the best growth stocks for 2024 here. How were Avanos Medical's earnings last quarter? Avanos Medical, Inc. (NYSE:AVNS) posted its earnings results on Thursday, May, 2nd. The company reported $0.19 EPS for the quarter, missing analysts' consensus estimates of $0.21 by $0.02. The business's quarterly revenue was up 4.3% on a year-over-year basis. What is Joseph F. Woody's approval rating as Avanos Medical's CEO? 32 employees have rated Avanos Medical Chief Executive Officer Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among the company's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Who are Avanos Medical's major shareholders? Top institutional shareholders of Avanos Medical include Tributary Capital Management LLC (1.62%), Bank of New York Mellon Corp (0.83%) and Concourse Financial Group Securities Inc.. Insiders that own company stock include Michael Greiner, Julie Ann Shimer and Patrick J Oleary. View institutional ownership trends. How do I buy shares of Avanos Medical? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Avanos Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Pfizer (PFE), Procter & Gamble (PG), Johnson & Johnson (JNJ) and RTX (RTX). This page (NYSE:AVNS) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avanos Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avanos Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
